Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Role of a second chemotherapy in recurrent malignant glioma patients who progress on a bevacizumab-containing regimen

Role of a second chemotherapy in recurrent malignant glioma patients who progress on a bevacizumab-containing regimen. Journal of Clinical Oncology. 2008; (supplement):abstr 2008.


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.